198 related articles for article (PubMed ID: 15786392)
1. [Type 2 diabetic nephropathy: clinical course and prevention proposals 2004].
Tarchini R; Bottini E; Botti P; Marseglia CD; Talassi E; Baraldi O; Lambertini D; Gaetti L; Bellomi A
G Ital Nefrol; 2005; 22 Suppl 31():S15-9. PubMed ID: 15786392
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
3. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy in children with type 1 diabetes mellitus in Bahrain.
Al-Hermi BE; Al-Abbasi AM; Rajab MH; Al-Jenaidi FA; Al-Ekri ZE
Saudi Med J; 2005 Feb; 26(2):294-7. PubMed ID: 15770309
[TBL] [Abstract][Full Text] [Related]
5. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
6. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
Molitch ME
Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
[TBL] [Abstract][Full Text] [Related]
7. New and old markers of progression of diabetic nephropathy.
Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
[TBL] [Abstract][Full Text] [Related]
8. Etiology, diagnosis, and prevention of renal involvement in insulin-dependent diabetes mellitus.
Chiumello G; Beccaria L; Meschi F; Mistura L; Brambilla P; Bognetti E
Pediatrician; 1983-1985; 12(4):199-207. PubMed ID: 6400450
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
10. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
11. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy.
Ritz E
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
Conti AA
Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
[TBL] [Abstract][Full Text] [Related]
14. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.
Zerbini G; Bonfanti R; Meschi F; Bognetti E; Paesano PL; Gianolli L; Querques M; Maestroni A; Calori G; Del Maschio A; Fazio F; Luzi L; Chiumello G
Diabetes; 2006 Sep; 55(9):2620-5. PubMed ID: 16936212
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
16. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
17. [Hospital-primary care teamwork in nephrology: 'preventive' epidemiology of diabetic nephropathy].
Russo D; Vico A; Monterisi F; Biga ML; Falanga R; Mancini A; Teutonico A; Losappio R; Gruppo di Integrazione Territtorio-Ospedale In Nefrologia GI
G Ital Nefrol; 2007; 24 Suppl 38():83-6. PubMed ID: 17922455
[TBL] [Abstract][Full Text] [Related]
18. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
19. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
